Lumenis Stellar M22

IPL multi-app platform · Updated M22, larger IPL spot

CurrentFDA ClearedBe the first to review

What it's actually cleared for: Modular IPL + laser platform cleared for benign vascular/pigmented lesions, hair removal and inflammatory acne

Last verified: August 6, 2026 · How we verify

New: $90k–$130k|Used: $55k–$85kmarket estimate, no email required

Save device

Bottom line

The closest thing to a default IPL platform in US dermatology — massive install base, the best-documented IPL science in the category, and a rare non-ablative fractional (ResurFx) with no per-treatment consumable. Not cheap new (low six figures configured with IPL + ResurFx) and Lumenis reps push module bundles hard, but revenue versatility per square foot is excellent. Buy it if IPL photofacials are a core menu item and you want the Photofractional combo story; skip it for hair-removal-only needs. The deep used market lets you enter at half price with acceptable risk.

Overview

Current M22 generation

How it works

The science

Multi-application platform with up to four modules: Universal IPL (515-1200nm broadband), ResurFx (1565nm non-ablative fractional fiber laser), multi-spot long-pulse Nd:YAG 1064nm, and Q-switched Nd:YAG. The IPL uses Optimal Pulse Technology for square, consistent pulses targeting melanin and hemoglobin — sun damage, rosacea, telangiectasias, photoaging. ResurFx creates microscopic dermal coagulation columns for texture, pores, acne scars, striae with minimal downtime. Nd:YAG handles leg veins and deeper vascular lesions. Photofractional is the marketed same-day IPL + ResurFx combo.

Patented tech

OPT is capacitor-controlled square-pulse delivery — energy stays flat across the pulse instead of spiking, why M22 IPL burns less and treats more predictably than cheap IPLs. ExpertFilters: nine snap-in wavelength cutoff filters (515-695nm plus dual-band vascular) tuning one handpiece to different targets and skin types.

Origin

Lumenis Be Ltd., Yokneam, Israel.

FDA & regulatory status

FDA ClearedCleared via 510(k)

What it's actually cleared for:

Modular IPL + laser platform cleared for benign vascular/pigmented lesions, hair removal and inflammatory acne

510(k) numbers

K193500; K250809

Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.

Treatment economics

What practices charge

IPL photofacials $350-600/session, packages of 3 at $900-1,500. ResurFx $500-1,000/session; Photofractional $650-1,200, commonly 3 sessions for $1,800-3,000. Vein/pigment spot treatments $150-400.

Consumables & recurring cost

ResurFx has no consumable tip — a genuine differentiator against Fraxel. IPL costs are flashlamp and sapphire lightguides: ~$1,500-4,000/year for a busy practice, a few dollars per treatment. Filters last years.

Ideal for

Best-fit practice

General medspa or derm practice with a broad menu and Fitzpatrick I-IV clientele — the 35-65 female photoaging demographic is the volume driver. Rewards 15+ IPL treatments weekly; also a strong dry-eye/MGD crossover play (ophthalmology overlap, a real referral channel).

Compliance

Medical director & delegation

Class II prescription device; IPL and non-ablative laser delegable to RNs/aestheticians (state-dependent) under a supervising physician with standing orders — no ablative-tier restrictions.

Contraindications & screening

Recent tanning, isotretinoin within 6 months, photosensitizing meds, pregnancy, active infection or skin cancer in the area, melasma-prone and Fitzpatrick V-VI for IPL (high PIH risk). ResurFx safer in darker types with conservative settings.

Ownership

Warranty & service

1-year standard; extended $8,000-15,000/year by modules. Lumenis US coverage good in metros, slower rurally; third-party service and parts widely available.

Resale & used market

One of the most liquid used aesthetic devices — legacy M22s $25-50k, Stellar units $45-75k by modules and lamp counts. Values stable because IPL demand never fades; verify Lumenis will support a transferred unit.